Identification of salivary metabolomic biomarkers for oral cancer screening

Shigeo Ishikawa, Masahiro Sugimoto, Kenichiro Kitabatake, Ayako Sugano, Marina Nakamura, Miku Kaneko, Sana Ota, Kana Hiwatari, Ayame Enomoto, Tomoyoshi Soga, Masaru Tomita, Mitsuyoshi Iino

Research output: Contribution to journalArticle

44 Citations (Scopus)

Abstract

The objective of this study was to explore salivary metabolite biomarkers by profiling both saliva and tumor tissue samples for oral cancer screening. Paired tumor and control tissues were obtained from oral cancer patients and whole unstimulated saliva samples were collected from patients and healthy controls. The comprehensive metabolomic analysis for profiling hydrophilic metabolites was conducted using capillary electrophoresis time-of-flight mass spectrometry. In total, 85 and 45 metabolites showed significant differences between tumor and matched control samples, and between salivary samples from oral cancer and controls, respectively (P < 0.05 correlated by false discovery rate); 17 metabolites showed consistent differences in both saliva and tissue-based comparisons. Of these, a combination of only two biomarkers yielded a high area under receiver operating characteristic curves (0.827; 95% confidence interval, 0.726-0.928, P < 0.0001) for discriminating oral cancers from controls. Various validation tests confirmed its high generalization ability. The demonstrated approach, integrating both saliva and tumor tissue metabolomics, helps eliminate pseudo-molecules that are coincidentally different between oral cancers and controls. These combined salivary metabolites could be the basis of a clinically feasible method of non-invasive oral cancer screening.

Original languageEnglish
Article number31520
JournalScientific Reports
Volume6
DOIs
Publication statusPublished - 2016 Aug 19

Fingerprint

Metabolomics
Mouth Neoplasms
Early Detection of Cancer
Biomarkers
Saliva
Neoplasms
Capillary Electrophoresis
ROC Curve
Mass Spectrometry
Confidence Intervals

ASJC Scopus subject areas

  • General

Cite this

Ishikawa, S., Sugimoto, M., Kitabatake, K., Sugano, A., Nakamura, M., Kaneko, M., ... Iino, M. (2016). Identification of salivary metabolomic biomarkers for oral cancer screening. Scientific Reports, 6, [31520]. https://doi.org/10.1038/srep31520

Identification of salivary metabolomic biomarkers for oral cancer screening. / Ishikawa, Shigeo; Sugimoto, Masahiro; Kitabatake, Kenichiro; Sugano, Ayako; Nakamura, Marina; Kaneko, Miku; Ota, Sana; Hiwatari, Kana; Enomoto, Ayame; Soga, Tomoyoshi; Tomita, Masaru; Iino, Mitsuyoshi.

In: Scientific Reports, Vol. 6, 31520, 19.08.2016.

Research output: Contribution to journalArticle

Ishikawa, S, Sugimoto, M, Kitabatake, K, Sugano, A, Nakamura, M, Kaneko, M, Ota, S, Hiwatari, K, Enomoto, A, Soga, T, Tomita, M & Iino, M 2016, 'Identification of salivary metabolomic biomarkers for oral cancer screening', Scientific Reports, vol. 6, 31520. https://doi.org/10.1038/srep31520
Ishikawa S, Sugimoto M, Kitabatake K, Sugano A, Nakamura M, Kaneko M et al. Identification of salivary metabolomic biomarkers for oral cancer screening. Scientific Reports. 2016 Aug 19;6. 31520. https://doi.org/10.1038/srep31520
Ishikawa, Shigeo ; Sugimoto, Masahiro ; Kitabatake, Kenichiro ; Sugano, Ayako ; Nakamura, Marina ; Kaneko, Miku ; Ota, Sana ; Hiwatari, Kana ; Enomoto, Ayame ; Soga, Tomoyoshi ; Tomita, Masaru ; Iino, Mitsuyoshi. / Identification of salivary metabolomic biomarkers for oral cancer screening. In: Scientific Reports. 2016 ; Vol. 6.
@article{ebbaa9d62bd64dd7a8aaad1bfda5b607,
title = "Identification of salivary metabolomic biomarkers for oral cancer screening",
abstract = "The objective of this study was to explore salivary metabolite biomarkers by profiling both saliva and tumor tissue samples for oral cancer screening. Paired tumor and control tissues were obtained from oral cancer patients and whole unstimulated saliva samples were collected from patients and healthy controls. The comprehensive metabolomic analysis for profiling hydrophilic metabolites was conducted using capillary electrophoresis time-of-flight mass spectrometry. In total, 85 and 45 metabolites showed significant differences between tumor and matched control samples, and between salivary samples from oral cancer and controls, respectively (P < 0.05 correlated by false discovery rate); 17 metabolites showed consistent differences in both saliva and tissue-based comparisons. Of these, a combination of only two biomarkers yielded a high area under receiver operating characteristic curves (0.827; 95{\%} confidence interval, 0.726-0.928, P < 0.0001) for discriminating oral cancers from controls. Various validation tests confirmed its high generalization ability. The demonstrated approach, integrating both saliva and tumor tissue metabolomics, helps eliminate pseudo-molecules that are coincidentally different between oral cancers and controls. These combined salivary metabolites could be the basis of a clinically feasible method of non-invasive oral cancer screening.",
author = "Shigeo Ishikawa and Masahiro Sugimoto and Kenichiro Kitabatake and Ayako Sugano and Marina Nakamura and Miku Kaneko and Sana Ota and Kana Hiwatari and Ayame Enomoto and Tomoyoshi Soga and Masaru Tomita and Mitsuyoshi Iino",
year = "2016",
month = "8",
day = "19",
doi = "10.1038/srep31520",
language = "English",
volume = "6",
journal = "Scientific Reports",
issn = "2045-2322",
publisher = "Nature Publishing Group",

}

TY - JOUR

T1 - Identification of salivary metabolomic biomarkers for oral cancer screening

AU - Ishikawa, Shigeo

AU - Sugimoto, Masahiro

AU - Kitabatake, Kenichiro

AU - Sugano, Ayako

AU - Nakamura, Marina

AU - Kaneko, Miku

AU - Ota, Sana

AU - Hiwatari, Kana

AU - Enomoto, Ayame

AU - Soga, Tomoyoshi

AU - Tomita, Masaru

AU - Iino, Mitsuyoshi

PY - 2016/8/19

Y1 - 2016/8/19

N2 - The objective of this study was to explore salivary metabolite biomarkers by profiling both saliva and tumor tissue samples for oral cancer screening. Paired tumor and control tissues were obtained from oral cancer patients and whole unstimulated saliva samples were collected from patients and healthy controls. The comprehensive metabolomic analysis for profiling hydrophilic metabolites was conducted using capillary electrophoresis time-of-flight mass spectrometry. In total, 85 and 45 metabolites showed significant differences between tumor and matched control samples, and between salivary samples from oral cancer and controls, respectively (P < 0.05 correlated by false discovery rate); 17 metabolites showed consistent differences in both saliva and tissue-based comparisons. Of these, a combination of only two biomarkers yielded a high area under receiver operating characteristic curves (0.827; 95% confidence interval, 0.726-0.928, P < 0.0001) for discriminating oral cancers from controls. Various validation tests confirmed its high generalization ability. The demonstrated approach, integrating both saliva and tumor tissue metabolomics, helps eliminate pseudo-molecules that are coincidentally different between oral cancers and controls. These combined salivary metabolites could be the basis of a clinically feasible method of non-invasive oral cancer screening.

AB - The objective of this study was to explore salivary metabolite biomarkers by profiling both saliva and tumor tissue samples for oral cancer screening. Paired tumor and control tissues were obtained from oral cancer patients and whole unstimulated saliva samples were collected from patients and healthy controls. The comprehensive metabolomic analysis for profiling hydrophilic metabolites was conducted using capillary electrophoresis time-of-flight mass spectrometry. In total, 85 and 45 metabolites showed significant differences between tumor and matched control samples, and between salivary samples from oral cancer and controls, respectively (P < 0.05 correlated by false discovery rate); 17 metabolites showed consistent differences in both saliva and tissue-based comparisons. Of these, a combination of only two biomarkers yielded a high area under receiver operating characteristic curves (0.827; 95% confidence interval, 0.726-0.928, P < 0.0001) for discriminating oral cancers from controls. Various validation tests confirmed its high generalization ability. The demonstrated approach, integrating both saliva and tumor tissue metabolomics, helps eliminate pseudo-molecules that are coincidentally different between oral cancers and controls. These combined salivary metabolites could be the basis of a clinically feasible method of non-invasive oral cancer screening.

UR - http://www.scopus.com/inward/record.url?scp=84983370773&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84983370773&partnerID=8YFLogxK

U2 - 10.1038/srep31520

DO - 10.1038/srep31520

M3 - Article

C2 - 27539254

AN - SCOPUS:84983370773

VL - 6

JO - Scientific Reports

JF - Scientific Reports

SN - 2045-2322

M1 - 31520

ER -